Genetic spectrum of MCM3AP and its relationship with phenotype of Charcot‐Marie‐Tooth disease

Mutations in MCM3AP have recently been reported to cause autosomal recessive Charcot‐Marie‐Tooth disease (CMT). However, only nine CMT families with MCM3AP mutations have been reported and genotype‐phenotype correlation remains unclear. This study aimed to investigate the genetic spectrum of MCM3AP...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the peripheral nervous system 2020-06, Vol.25 (2), p.107-111
Main Authors: Dong, Hai‐Lin, Wei, Qiao, Li, Jia‐Qi, Li, Hong‐Fu, Bai, Ge, Ma, Huan, Wu, Zhi‐Ying
Format: Article
Language:English
Subjects:
Charcot‐Marie‐tooth disease
Correlation analysis
Genetic counseling
Genotype & phenotype
Genotypes
genotype‐phenotype correlation
Intellectual disabilities
MCM3AP
mRNA turnover
Mutation
Peripheral neuropathy
Phenotypes
Reverse transcription
Splicing
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mutations in MCM3AP have recently been reported to cause autosomal recessive Charcot‐Marie‐Tooth disease (CMT). However, only nine CMT families with MCM3AP mutations have been reported and genotype‐phenotype correlation remains unclear. This study aimed to investigate the genetic spectrum of MCM3AP and its relationship with phenotype of CMT. Whole‐exome sequencing (WES) was performed in the family and variants were validated by Sanger sequencing. Reverse transcription‐PCR (RT‐PCR) were performed in splicing analysis. We reported a novel splicing variant (c.5634‐1G>T) and a known missense variant (c.2633G>A, p.Arg878His). Functional studies showed that c.5634‐1G>T led to splicing defect and aberrant transcript eliminated by nonsense‐mediated mRNA decay. The symptom of the patient was less severe and slowly progressed with axonal peripheral neuropathy compared to the reported CMT patients. Genotype‐phenotype correlation analysis indicated that affected individuals with null mutations presented with delayed independent walking. The percentage of intellectual disability and loss of ambulation in the null group tended to be greater, although this failed to reach statistical significance. Our findings expand the genetic spectrum of MCM3AP and suggest that genotype‐phenotype correlation would help genetic counseling of MCM3AP in CMT patients.
ISSN:1085-9489
1529-8027
DOI:10.1111/jns.12377